BridgeMD
Compares treatment options for Immediate Implant
Official title Xengenic Cortical Membranes Versus Connective Tissue Graft With Coronally Advanced Flap for the Treatment of Peri-implant Soft Tissue Dehiscences: A Randomized, Controlled Clinical Trial
ClinicalTrials.gov ID: NCT06588998
What this study is testing
- What it's testing
- Peri-implant soft tissue dehiscences represent a common complication in implant dentistry, often leading to esthetic and functional challenges. Current treatment options, including Xengenic cortical membranes and connective tissue graft with coronally advanced flap, aim to promote soft tissue regeneration and improve clinical outcomes.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 50
You may be able to join if
- Adults (20-50) years old. peri-implant soft tissue dehiscence . Thin gingival phenotype. Optimal compliance as evidenced by no missing treatment...
You likely can't join if
- Medically compromised patients and systemic conditions precluding implant and periodontal surgery. Smokers, diabetics, pregnant or lactating women...
The study team makes the final eligibility decision.
Where it's taking place
- Tanta, Gharbia Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tanta, Gharbia Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.